Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Novel monoclonal antibodies presented by the University of Texas System

Jan. 30, 2014

Patient recruitment begins in phase I trial of Ribological's personalized anticancer vaccine

Jan. 29, 2014

Cedars-Sinai begins phase I trial of brain cancer vaccine

Jan. 29, 2014

Phase I trial to evaluate IGN-523 in acute myeloid leukemia

Jan. 28, 2014

Immune Design treats first patient in phase I trial of IDG-100

Jan. 28, 2014

KIF20A-derived peptide plus gemcitabine evaluated in pancreatic cancer trial

Jan. 24, 2014

California Stem Cell submits phase II trial protocol to FDA for Ovapuldencel-T

Jan. 24, 2014

Advaxis and Biocon to collaborate on novel cancer immunotherapy

Jan. 23, 2014

OMP-59R5 proves active against metastatic pancreatic cancer

Jan. 23, 2014

Simtuzumab well tolerated in phase I and II trials

Jan. 21, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...